Eun-Sil Shelley Hwang, MD, on DCIS: Results of the CALGB 40903 Trial

2017 San Antonio Breast Cancer Symposium
Tweet this page

Eun-Sil Shelley Hwang, MD, of Duke University Medical Center, discusses study findings on primary endocrine therapy for estrogen receptor–positive ductal carcinoma in situ (Abstract GS5-05).

Advertisement

Advertisement



Advertisement